Advertisement

Infections in Immunocompromised Children

  • P. M. Flynn
  • W. T. Hughes
Part of the UICC International Union Against Cancer book series (1360)

Abstract

Immunosuppressed children with cancer are constantly at risk of developing infections. The extent of susceptibility depends on the integrity of the various components of the immune system and the virulence and number of microbes to which the individual is exposed. Many other factors, including the type and stage of malignancy, type and extent of antimicrobial and anticancer therapies, integrity of the skin and mucous membranes, duration of hospitalization, and nutritional status also affect the risk of infection.

Keywords

Invasive Aspergillosis Bone Marrow Transplant Recipient Varicella Zoster Virus Infection Febrile Neutropenic Patient Exit Site Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Langley J, Gold R (1988) Sepsis in febrile neutropenic children with cancer. Pediatr Infect Dis J 7: 34–37PubMedCrossRefGoogle Scholar
  2. 2.
    Pizzo PA, Ladisch S, Robichaud K (1980) Treatment of gram-positive septicemia in cancer patients. Cancer 45: 206–207PubMedCrossRefGoogle Scholar
  3. 3.
    Wade JC, Schimpff SC, Newman KA, Wiernik PH (1982) Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia. Ann Intern Med 97: 503–508Google Scholar
  4. 4.
    Patrick CC (1990) Coagulase-negative staphylococci: pathogens with increasing clinical significance. J Pediatr 116: 497–507PubMedCrossRefGoogle Scholar
  5. 5.
    Wade JC (1989) Antibiotic therapy for the febrile granulocytopenic cancer patient: combination therapy vs monotherapy. Rev Infect Dis 11: S1572–S1581PubMedCrossRefGoogle Scholar
  6. 6.
    Cohen J, Donnelly JP, Worsley AM, Catovsky D, Goldman JM, Galton DAG (1983) Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia. Lancet 2: 1452–1454PubMedCrossRefGoogle Scholar
  7. 7.
    Sotiropoulos SV, Jackson MA, Woods GM, Hicks RA, Cullen J, Freeman AI (1989) Alpha-streptococcal septicemia in leukemic children treated with continuous or large dosage intermittent cytosine arabinoside. Pediatr Infect Dis J 8: 755–758PubMedCrossRefGoogle Scholar
  8. 8.
    Shenep JL, Hughes WT, Roberson PK, Blankenship KR, Baker DK Jr, Meyer WH, Gigliotti F, Sixbey JW, Santana VM, Feldman S, Lott L (1988) Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer. N Engl J Med 319: 1053–1058PubMedCrossRefGoogle Scholar
  9. 9.
    Johnson MP, Ramphai R (1990) ß-Lactam-resistant Enterobacter bacteremia in febrile neutropenic patients receiving monotherapy. J Infect Dis 162: 981–983PubMedCrossRefGoogle Scholar
  10. 10.
    Whitby JL, Rampling A (1972) Pseudomonas aeruginosa contamination in domestic and hospital environments. Lancet 1: 15–17Google Scholar
  11. 11.
    Pilon VA, Echols RM, Celo JS, Elmendorf SL (1987) Disseminated Pneumocystis carinii infection in AIDS. N Engl J Med 316: 1410–1411PubMedCrossRefGoogle Scholar
  12. 12.
    Masur H, Lane HC, Kovacs JA, Allegra CJ, Edman JC (1989) Pneumocystis pneumonia: from bench to clinic. Ann Intern Med 111: 813–826PubMedGoogle Scholar
  13. 13.
    Navin TR, Fontaine RE (1984) Intravenous versus intramuscular administration of pentamidine. N Engl J Med 311: 1701–1702PubMedGoogle Scholar
  14. 14.
    Hughes WT, Rivera GK, Schell MJ, Thornton D, Lott L (1987) Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 316: 1627–1632PubMedCrossRefGoogle Scholar
  15. 15.
    Henson D, Siegel SE, Fuccillo DA, Matthew E, Levine AS (1972) Cytomegalovirus infections during acute childhood leukemia. J Infect Dis 126: 469–481PubMedCrossRefGoogle Scholar
  16. 16.
    Reed EC, Bowdin RA, Dandliker PS, Lilleby KE, Meyers JD (1988) Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann Intern Med 109: 783–788PubMedGoogle Scholar
  17. 17.
    Emanuel D, Cunningham I, Jules-Elysee K, Brochstein JA, Kernan NA, Laver J, Stover D, White DA, Fels A, Polsky B, Castro-Malaspina H, Peppard JR, Bartus P, Hammerling U, O’Reilly RJ (1988) Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin. Ann Intern Med 109: 777–782PubMedGoogle Scholar
  18. 18.
    Feldman S, Hughes WT, Daniel CB (1975) Varicella in children with cancer: seventy-seven cases. Pediatrics 56: 388–397PubMedGoogle Scholar
  19. 19.
    Feldman S, Hughes WT, Kim HY (1973) Herpes zoster in children with cancer. Am J Dis Child 126: 178–184PubMedGoogle Scholar
  20. 20.
    Feldman S, Lott L (1987) Varicella in children with cancer: impact of antiviral therapy and prophylaxis. Pediatrics 80: 465–472PubMedGoogle Scholar
  21. 21.
    Hughes WT (1982) Systemic candidiasis: a study of 109 fatal cases. Pediatr Infect Dis J 1: 11–18CrossRefGoogle Scholar
  22. 22.
    Meunier F (1989) New methods for delivery of antifungal agents. Rev Infect Dis 11: S1605–S1612PubMedCrossRefGoogle Scholar
  23. 23.
    Meunier F (1987) Prevention of mycoses in immunocompromised patients. Rev Infect Dis 9: 408–416PubMedCrossRefGoogle Scholar
  24. 24.
    Bartley DL, Hughes WT, Parvey LS, Parham D (1982) Computed tomography of hepatic and splenic fungal abscesses in leukemic children. Pediatr Infect Dis J 1: 317–321CrossRefGoogle Scholar
  25. 25.
    Thaler M, Pastakia B, Shawker TH, O’Leary T, Pizzo PA (1988) Hepatic candidiasis in cancer patients: the evolving picture of the syndrome. Ann Intern Med 108: 88–100PubMedGoogle Scholar
  26. 26.
    Yu, VL, Muder RR, Poorsattar A (1986) Significance of isolation of aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study. Am J Med 81: 249–254Google Scholar
  27. 27.
    Denning DW, Stevens DA (1990) Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis 12: 1147–1201PubMedCrossRefGoogle Scholar
  28. 28.
    Denning DW, Tucker RM, Hanson LH, Stevens DA (1989) Treatment of invasive aspergillosis with itraconazole. Am J Med 86: 791–800PubMedCrossRefGoogle Scholar
  29. 29.
    Schimpff S, Satterlee W, Young VM, Serpick A (1971) Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 284: 1061–1065PubMedCrossRefGoogle Scholar
  30. 30.
    Hughes WT, Armstrong D, Bodey GP, Feld R, Mandell GL, Meyers JD, Pizzo PA, Schimpff SC, Shenep JL, Wade JC, Young LS, Yow MD (1990) Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis 161: 381–396PubMedCrossRefGoogle Scholar
  31. 31.
    Bodey GP, Buckley M, Sathe YS, Freireich EJ (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64: 328–340PubMedGoogle Scholar
  32. 32.
    Shenep JL (1990) Combination and single-agent empirical antibacterial therapy for febrile cancer patients with neutropenia and mucositis. NCI Monogr 9: 117–122PubMedGoogle Scholar
  33. 33.
    Flynn PM (1992) Vascular access device infections: In: Patrick CC (ed) Infections in immunocompromised infants and children. Churchill Livingston, New York (in apress)Google Scholar
  34. 34.
    Press OW, Ramsey PG, Larson EB, Fefer A, Hickman RO (1984) Hickman catheter infections in patients with malignancies. Medicine (Baltimore) 63: 189–200Google Scholar
  35. 35.
    Meyers JD (1986) Infection in bone marrow transplant recipients. Am J Med 81: 27–38PubMedCrossRefGoogle Scholar
  36. 36.
    Engelhard D, Marks MI, Good RA (1986) Infections in bone marrow transplant recipients. J Pediatr 108: 335–346PubMedCrossRefGoogle Scholar
  37. 37.
    Feldman S, Gigliotti F, Shenep JL, Roberson PK, Lott L (1990) Risk of Haemophilus influenzae type b disease in children with cancer and response of immunocompromised leukemic children to a conjugate vaccine. J Infect Dis 161: 926–931PubMedCrossRefGoogle Scholar
  38. 38.
    Peter G (ed) (1988) Report of the Committee on Infectious Diseases, 21st edn. American Academy of Pediatrics, Elk Grove Village, Illinois, p 331Google Scholar
  39. 39.
    Walsh TJ, Schimpff SC (1983) Prevention of infection among patients with cancer. Eur J Cancer Clin Oncol 19: 1333–1344PubMedCrossRefGoogle Scholar
  40. 40.
    Valdivieso M, Cabanillas F, Keating M, Barkley HT, Murphy WK, Burgess MA, Frazier H, Chen T, Bodey GP (1984) Effects of intensive induction chemotherapy for extensive-disease small cell bronchogenic carcinoma in protected environment-prophylactic antibiotic units. Am J Med 76: 405–412PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • P. M. Flynn
  • W. T. Hughes

There are no affiliations available

Personalised recommendations